To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06457503
Title A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer (TRANSPARENT)
Acronym TRANSPARENT
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Coherus Biosciences, Inc.
Indications
Therapies
Age Groups: senior | adult | child
Covered Countries USA | CAN


No variant requirements are available.